International Workshop on future research program with the high power Cyclotron of SPES-LNL

Session

Second Session: Radioisotopes for Medicine and advanced detectors

12 May 2025, 14:30

Villi Room (LNL)

Conveners

Second Session: Radioisotopes for Medicine and advanced detectors

• Alberto Quaranta (TIFPA - University of Trento)

68. Opening Talk (on line): TBD

Uli Koester (Institut Laue-Langevin, Grenoble)

12/05/2025, 14:30

67. Opening Talk: Radioligands

Laura Evangelista (HUMANITAS UNIVERSITY, Milano)

12/05/2025, 15:00

69. Feasibility production of 67/64Cu mixture with SPES cyclotron for the first radiopharmaceutical in-vivo studies

Liliana Mou (Istituto Nazionale di Fisica Nucleare)

12/05/2025, 15:30

70. Thick targets yields measurements with natV targets for the production of the theranostic 47Sc

Lucia De Dominicis (Istituto Nazionale di Fisica Nucleare)

12/05/2025, 15:50

71. Hybrid polysiloxanes and nanocomposite scintillators for high energy and medical physics applications

Dr Sara Maria Carturan (LNL-INFN)

12/05/2025, 16:10

72. Miniaturized Microdosimeters for Hadron Therapy AToMiQA -

Anna Bianchi (Istituto Nazionale di Fisica Nucleare)

12/05/2025, 16:30

17. AToMiQA – Young Researchers’ Grant 5th Commission INFN (2025-2026)

Anna Bianchi (Istituto Nazionale di Fisica Nucleare)

The new young researchers' grant AToMiQA has the aim of developing a microdosimetry system capable of measuring in high intensity beams. To this aim the newly commissioned LNL cyclotron offers a unique opportunity to test detectors starting with low beam currents to evaluate sensitivity and performance under minimal radiation exposure, then progressively increasing intensity to assess their...

13. Feasibility production of 67/64Cu mixture with SPES cyclotron for the first radiopharmaceutical in-vivo studies

Copper-67 (67Cu, T1/2 61.9 h), as well as Copper-64 (64Cu, T1/2 12.7 h), are under the spotlight of the scientific community as single isotopes for targeted radionuclide therapy, and as a pair for theragnostic applications thanks to the, β- and γ emissions of 67Cu and β- and β+ emission of 64Cu . Their half-lives are suitable for tracking radiopharmaceuticals with slow pharmacokinetics....

19. Hybrid polysiloxanes and nanocomposite scintillators for high energy and medical physics applications

Dr Sara Maria Carturan (LNL-INFN)

Organic scintillators have found widespread use in several fields of physics as radiation sensors, owing to their peculiar chemical and physical properties. They are lightweight, easy to produce in different volumes and shapes, they commonly offer a fast response and are also tissue-equivalent in medical dosimetry. In high energy physics, these features are harnessed to collect and reveal the...

14. Thick target yields measurements with natV targets for the production of the theranostic 47Sc

47Sc is an emerging medical radionuclide with potential in the field of theranostic applications. Its favourable decay characteristics, namely β- particles of 162.0 keV mean energy, γ rays of about 159 keV energy, and a half-life of 3.3492 d, make it suitable for use in the radiolabelling of radiopharmaceuticals for cancer diagnosis using SPECT (Single Photon Emission Computed Tomography)...